您当前所在的位置:首页 > 产品中心 > 产品信息
Paclitaxel_分子结构_CAS_33069-62-4)
点击图片或这里关闭

Paclitaxel

产品号 Bio-0076 公司名称 InterBioScreen
CAS号 33069-62-4 公司网站 http://www.ibscreen.com
分子式 C47H51NO14 电 话 +7 49652 40091
分子量 853.90614 传 真 +7 49652 40092
纯 度 电子邮件 screen@ibscreen.chg.ru
保 存 Chembase数据库ID: 1098

产品价格信息

请登录

产品别名

标题
Paclitaxel
IUPAC标准名
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl benzoate
IUPAC传统名
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl benzoate
别名
Taxol A
Yewtaxan
Anzatax

产品登记号

CAS号 33069-62-4

产品性质

应用领域 Antileukaemic and antineoplastic agent, esp. against melanoma and ovarian tumours
应用领域 Use limited by low solubility and scarce availability of Taxus brevifolia bark
应用领域 Biochemical tool extensively used to study cellular shape and function.
应用领域 Also shown to be active against oomycete fungi
生物来源 Isol. from the stem bark of Taxus brevifolia and Taxus cuspidata (Taxaceae)
生物活性机理 Interferes with the normal function of microtubule growth by hyper-stabilisation of their structure
生物活性机理 Binds to the beta subunit of tubulin

产品详细信息

参考文献

  • Wani, M.S. et al., J.A.C.S., 1971, 93, 2325, (isol, nmr, ms, ir, uv)
  • Kingston, D.G.I. et al., J. Nat. Prod., 1982, 45, 466-470, (2',7-di-Ac)
  • Suffness, M. et al., Alkaloids (N.Y.), 1985, 25, 10, (rev, pharmacol)
  • Horwitz, S.B. et al., Ann. N.Y. Acad. Sci., 1986, 466, 733, (rev, pharmacol)
  • Huang, C.H.O. et al., J. Nat. Prod., 1986, 49, 665, (isol, deriv)
  • Blechert, S. et al., Alkaloids (N.Y.), 1990, 39, 195, (rev, pharmacol)
  • Kingston, D.G.I. et al., J. Nat. Prod., 1990, 53, 1; 802, (bibl, rev)
  • Slichenmyer, W.J. et al., Anti-Cancer Drugs, 1991, 2, 519, (rev)
  • Kingston, D.G.I., Pharmacol. Ther., 1991, 52, 1, (rev, pharmacol)
  • Rose, W.C., Anti-Cancer Drugs, 1992, 3, 311, (rev)
  • Potier, P., Chem. Soc. Rev., 1992, 21, 113, (rev)
  • Young, D.H. et al., Experientia, 1992, 48, 882, (antifungal activity)
  • Chmurny, G.N. et al., J. Nat. Prod., 1992, 55, 414, (pmr, cmr)
  • Wheeler, N.C. et al., J. Nat. Prod., 1992, 55, 432, (occur)
  • Hilton, B.D. et al., J. Nat. Prod., 1992, 55, 1157, (pmr)
  • Falzone, C.J. et al., Tet. Lett., 1992, 33, 1169, (pmr, cmr)
  • Winkler, J.D. et al., Tetrahedron, 1992, 48, 6953, (rev)
  • Ojima, I. et al., Tetrahedron, 1992, 48, 6985, (synth)
  • Horwitz, S.B., Trends Pharmacol. Sci., 1992, 13, 134, (rev)
  • Wall, M.E., Chron. Drug Discovery, 1993, 3, 327, (rev)
  • Fleming, P.E. et al., J.A.C.S., 1993, 115, 805, (biosynth)
  • Stierle, A. et al., Science (Washington, D.C.), 1993, 260, 214, (isol, ms)
  • Williams, H.J. et al., Tetrahedron, 1993, 49, 6545, (pmr, conformn)
  • Zhang, H. et al., Yunnan Zhiwu Yanjiu, 1993, 15, 424; CA, 121, 78282e
  • Nicolaou, K.C. et al., Angew. Chem., Int. Ed., 1994, 33, 15, (rev)
  • Joel, S.P., Chem. Ind. (London), 1994, 172, (rev)
  • Sonnichsen, D.S. et al., Clin. Pharmacokinet., 1994, 27, 256, (rev, pharmacokinet)
  • Hongjie, Z. et al., Heterocycles, 1994, 38, 975
  • Hoke, S.H. et al., J. Nat. Prod., 1994, 57, 277, (ms)
  • Kerns, E.H. et al., J. Nat. Prod., 1994, 57, 1391, (ms)
  • Gimon, M.E. et al., J. Nat. Prod., 1994, 57, 1404, (ms)
  • Holton, R.A. et al., J.A.C.S., 1994, 116, 1597; 1599, (synth)
  • Fleming, P.E. et al., J.A.C.S., 1994, 116, 4137, (biosynth)
  • Nicolaou, K.C. et al., Nature (London), 1994, 367, 630, (synth)
  • Fleming, P.E. et al., Pure Appl. Chem., 1994, 66, 2045, (biosynth)
  • Kingston, D.G.I. et al., Tet. Lett., 1994, 35, 4483, (synth)
  • Georg, G.I. et al., ACS Symp. Ser., 1995, 583, (book)
  • Gao, Q. et al., Acta Cryst. C, 1995, 51, 295, (cryst struct)
  • Huizing, M.T. et al., J. Chromatogr., B: Biomed. Appl., 1995, 664, 373, (hplc)
  • Grothaus, P.G. et al., J. Nat. Prod., 1995, 58, 1003, (immunoassay)
  • Nicolaou, K.C. et al., J.A.C.S., 1995, 117, 624; 634; 645; 653, (synth)
  • Rowinsky, E.K. et al., N. Engl. J. Med., 1995, 332, 1004, (use, tox, rev)
  • Nogales, E. et al., Nature (London), 1995, 375, 424
  • Vyas, D.M. et al., Prog. Med. Chem., 1995, 32, 289, (rev)
  • Taxol: Science and Applications, Ed., Suffness, M, CRC Press, Boca Raton, USA, 1995, (book)
  • The Chemistry and Pharmacology of Taxol(R) and its Derivatives, (Ed. Farina, V.), Elsevier, 1995, (book)
  • Nicolaou, K.C. et al., Classics in Total Synthesis, Targets, Strategies, Methods, VCH, 1996, 655, (bibl, synth)
  • Danishefsky, S.J. et al., J.A.C.S., 1996, 118, 2843, (synth)
  • Heinstein, P. et al., J.C.S. Perkin 1, 1996, 845, (ms)
  • Gao, Q. et al., Tetrahedron, 1996, 52, 2291, (cryst struct)
  • Rao, K.V., J. Het. Chem., 1997, 34, 675-680, (synth)
  • Wender, P.A. et al., J.A.C.S., 1997, 119, 2757, (synth)
  • Gennari, C. et al., J.O.C., 1997, 62, 4746-4755, (synth)
  • Hezari, M. et al., Planta Med., 1997, 63, 291-295, (biosynth, rev)
  • Shiina, I. et al., Chem. Lett., 1998, 3-4, (synth)
  • Eisenhauer, E.A. et al., Drugs, 1998, 55, 5-30, (pharmacol, rev)
  • Mukaiyama, T. et al., Chem. Eur. J., 1999, 5, 121-161, (Taxol, synth, rev)
  • Ranson, M. et al., Expert Opin. Invest. Drugs, 1999, 8, 837-848
  • Das, B. et al., Indian J. Chem., Sect. B, 1999, 38, 1018-1024, (rev)
  • Baloglu, E. et al., J. Nat. Prod., 1999, 62, 1068-1071, (synth)
  • Martindale, The Extra Pharmacopoeia, 32nd edn., Pharmaceutical Press, 1999, 556
  • Kusama, H. et al., J.A.C.S., 2000, 122, 3811-3820, (synth)
  • Walker, K. et al., Phytochemistry, 2001, 58, 1-7, (biosynth, rev)
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, TAH775